Cite
APA Citation
Huth, F., Schiller, H., Jin, Y., Poller, B., Schuhler, C., Weis, W., Woessner, R., Drollmann, A., & End, P. (2022). novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug‐drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling. Clinical and translational science, 15(1), 118–129. http://access.bl.uk/ark:/81055/vdc_100148624154.0x000018